
    
      This is a randomized, multicenter, double-blind, split-face study in subjects seeking
      nasolabial fold correction. Subjects will be treated with Revanesse Ultra + in the NLF on one
      side of the face and Revanesse Ultra in the NLF on the other side of the face. The side of
      the face for each study product will be randomly assigned. The investigator and the subject
      will be blinded to the treatment; injections of the study product will be performed by an
      unblinded injecting investigator.

      At each visit, investigator and subject evaluations of the treated areas will be performed
      and recorded
    
  